This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 6/18/1990: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer.
Also known as
- Brand name: Ergamisol